Publications by authors named "Anatoli Gleiberman"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

1,524

Total Likes

57

Extended Reach

89,917

Social Features

20
T
The cell-permeable iron chelator M606 inhibits MYCN-driven neuroblastoma via an E2F3-mediated response.
Ruby Pandher, Chengyuan Xue, Laura D Gamble, Giorgio Milazzo, Simone Di Giacomo, Anatoli S Gleiberman

Proc Natl Acad Sci U S A· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toll-Like-Receptor 5 protects against pulmonary fibrosis by reducing lung dysbiosis.
Yosuke Sakamachi, Emma Wiley, Alma Solis, Collin G Johnson, Xianglin Meng, Anatoli Gleiberman

bioRxiv· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer Relevance of Circulating Antibodies Against LINE-1 Antigens in Humans.
Alexandra V Vylegzhanina, Ivan A Bespalov, Ksenia A Novototskaya-Vlasova, Brandon M Hall, Anatoli S Gleiberman

Cancer Res Commun· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammatory response to retrotransposons drives tumor drug resistance that can be prevented by reverse transcriptase inhibitors.
Ksenia A Novototskaya-Vlasova, Nickolay S Neznanov, Ivan Molodtsov, Brandon M Hall, Mairead Commane, Anatoli S Gleiberman

Proc Natl Acad Sci U S A· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resistance of bone marrow stroma to genotoxic preconditioning is determined by p53.
Natalia Fedtsova, Elena A Komarova, Kellee F Greene, Liliya R Novototskaya, Ivan Molodtsov, Anatoli S Gleiberman

Cell Death Dis· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A deimmunized and pharmacologically optimized Toll-like receptor 5 agonist for therapeutic applications.
Vadim Mett, Oleg V Kurnasov, Ivan A Bespalov, Ivan Molodtsov, Craig M Brackett, Anatoli S Gleiberman

Commun Biol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune checkpoint protein VSIG4 as a biomarker of aging in murine adipose tissue.
Brandon M Hall, Anatoli S Gleiberman, Evguenia Strom, Peter A Krasnov, David Frescas

Aging Cell· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TLR5 agonist entolimod reduces the adverse toxicity of TNF while preserving its antitumor effects.
Gary J Haderski, Bojidar M Kandar, Craig M Brackett, Ilia M Toshkov, Christopher P Johnson, Anatoli S Gleiberman

PLoS One· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Superior cancer preventive efficacy of low versus high dose of mTOR inhibitor in a mouse model of prostate cancer.
Marina P Antoch, Michelle Wrobel, Bryan Gillard, Karen K Kuropatwinski, Ilia Toshkov, Anatoli S Gleiberman

Oncotarget· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Murine mesenchymal cells that express elevated levels of the CDK inhibitor p16(Ink4a) in vivo are not necessarily senescent.
David Frescas, Brandon M Hall, Evguenia Strom, Lauren P Virtuoso, Mahima Gupta, Anatoli S Gleiberman

Cell Cycle· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitigation of Radiation-Induced Epithelial Damage by the TLR5 Agonist Entolimod in a Mouse Model of Fractionated Head and Neck Irradiation.
Ilia A Toshkov, Anatoli S Gleiberman, Vadim L Mett, Alan D Hutson, Anurag K Singh

Radiat Res· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physiological frailty index (PFI): quantitative in-life estimate of individual biological age in mice.
Marina P Antoch, Michelle Wrobel, Karen K Kuropatwinski, Ilya Gitlin, Katerina I Leonova, Anatoli S Gleiberman

Aging (Albany NY)· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Senescent cells expose and secrete an oxidized form of membrane-bound vimentin as revealed by a natural polyreactive antibody.
David Frescas, Christelle M Roux, Semra Aygun-Sunar, Anatoli S Gleiberman, Peter Krasnov

Proc Natl Acad Sci U S A· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aging of mice is associated with p16(Ink4a)- and β-galactosidase-positive macrophage accumulation that can be induced in young mice by senescent cells.
Brandon M Hall, Vitaly Balan, Anatoli S Gleiberman, Evguenia Strom, Peter Krasnov

Aging (Albany NY)· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Toll-Like Receptor 5 Agonist Entolimod Mitigates Lethal Acute Radiation Syndrome in Non-Human Primates.
Vadim I Krivokrysenko, Ilia A Toshkov, Anatoli S Gleiberman, Peter Krasnov, Inna Shyshynova

PLoS One· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A murine model of targeted infusion for intracranial tumors.
Minhyung Kim, Tara A Barone, Natalia Fedtsova, Anatoli Gleiberman, Chandler D Wilfong

J Neurooncol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tissue-specific changes in molecular clocks during the transition from pregnancy to lactation in mice.
Theresa M Casey, Jennifer Crodian, Emily Erickson, Karen K Kuropatwinski, Anatoli S Gleiberman

Biol Reprod· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toll-like receptor-5 agonist Entolimod broadens the therapeutic window of 5-fluorouracil by reducing its toxicity to normal tissues in mice.
Bojidar M Kojouharov, Craig M Brackett, Jean M Veith, Christopher P Johnson, Ilya I Gitlin, Anatoli S Gleiberman

Oncotarget· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Central role of liver in anticancer and radioprotective activities of Toll-like receptor 5 agonist.
Lyudmila G Burdelya, Craig M Brackett, Bojidar Kojouharov, Ilya I Gitlin, Katerina I Leonova, Anatoli S Gleiberman

Proc Natl Acad Sci U S A· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Core circadian protein CLOCK is a positive regulator of NF-κB-mediated transcription.
Mary L Spengler, Karen K Kuropatwinski, Maria Comas, Alexander V Gasparian, Natalia Fedtsova, Anatoli S Gleiberman

Proc Natl Acad Sci U S A· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toll-like receptor 5 agonist protects mice from dermatitis and oral mucositis caused by local radiation: implications for head-and-neck cancer radiotherapy.
Lyudmila G Burdelya, Anatoli S Gleiberman, Ilia Toshkov, Semra Aygun-Sunar, Meghana Bapardekar

Int J Radiat Oncol Biol Phys· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic approaches identify adult pituitary stem cells.
Anatoli S Gleiberman, Tatyana Michurina, Juan M Encinas, Jose L Roig, Peter Krasnov

Proc Natl Acad Sci U S A· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cooperative regulation in development by SMRT and FOXP1.
Kristen Jepsen, Anatoli S Gleiberman, Can Shi, Daniel I Simon, Michael G Rosenfeld

Genes Dev· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neural potential of a stem cell population in the hair follicle.
John L Mignone, Jose L Roig-Lopez, Natalia Fedtsova, Dustin E Schones, Louis N Manganas, Anatoli Gleiberman

Cell Cycle· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis